Description
CJC-1295 (No DAC) 10mg + Ipamorelin 10mg – 20mg Research Peptide Blend
This research-grade blend combines CJC-1295 (No DAC), a tetrasubstituted GHRH analog,
with Ipamorelin, a selective ghrelin mimetic peptide, for laboratory investigation of
growth hormone–related biochemical pathways. Peer-reviewed findings describing coordinated
GHRH and GHSR pathway activity, including work that highlights the relevance of this combination in multi-receptor mechanistic studies. The blend provides a valuable tool for examining interactions involving GHRH receptor activation, ghrelin receptor (GHSR) signaling, and downstream intracellular mechanisms.
CJC-1295 (No DAC) is widely utilized in vitro to explore short-duration GHRH analog
activity, pituitary receptor signaling, and cyclic AMP–mediated intracellular pathways.
Ipamorelin is frequently employed to examine selective GHSR-associated cascades,
including calcium flux responses, second-messenger formation, and peptide–receptor
binding dynamics.
When used in controlled mechanistic models, this blend allows evaluation of complementary
pathway modulation, synergistic biochemical effects, and coordinated receptor-specific
intracellular signaling. The fixed-ratio formulation ensures consistent composition for
in-vitro assays requiring reproducible multi-peptide interaction profiles.
Important Information About This Research Product:
- Your vials are not empty — the lyophilized material collects at the bottom.
- All products arrive as lyophilized powder.
- Store in a cool, dry environment — short-term at 4°C, long-term at -20°C.
- This material is strictly for laboratory research use only — no instructions for
reconstitution, dosing, or administration can be provided.
